The Mode of Pretransplant Dialysis Does Not Affect Postrenal Transplant Outcomes in African Americans

Table 2

Dialysis modality and renal transplant outcomes.

	Hemodialysis; (𝑛=339)	Peritoneal dialysis; (𝑛=62)	𝑃 value
Patient survival (%)
1 year	96.8 ± 1.0	95.2 ± 2.7	ns
3 years	91.4 ± 1.5	90.3 ± 3.8	ns
5 years	84.1 ± 2.0	87.0 ± 4.3	ns
Graft survival (%)
1 year	92.6 ± 1.4	90.6 ± 3.8	ns
3 years	80.2 ± 2.2	75.8 ± 5.4	ns
5 years	67.1 ± 2.6	72.6 ± 5.7	ns
Outcomes (1st year)
DGF	130 (38.8%)	11 (17.7%)	P < 0.005
Vascular thrombosis	2	0
Systemic infections	99 (29.2%)	15 (24.2%)	P = 0.45
Wound infections	20 (5.9%)	2 (3.2%)	P = 0.36
Rejection	49 (14.5%)	4 (6.5%)	P = 0.10
Length of stay (d)	6.6 ± 3.3	6.6 ± 2.5	P = 0.99

Patient and graft survivals are given as percentage ± standard error, DGF: delayed graft function, ns: not significant (P > 0.05).